[Evaluation and use of the coronary and anti-arrhythmic drug Lidoflazin. Clinical, electrocardiographic, hemodynamic, and laboratory-chemical studies on 187 patients].
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy* / Q000503:physiopathology; D006321:Heart / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008013:Lidoflazine / Q000009:adverse effects / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D010879:Piperazines; D008013:Lidoflazine
Beurteilung und Anwendung der koronarund antiarrhythmisch wirksamen Substanz Lidoflazin. Klinische, elektrokardiographische, hämodynamische und laborchemische Untersuchungen bei 187 Patienten